Neonatal abstinence syndrome: UNODC a me nā poʻe akamai e kūkākūkā i ke kākoʻo no nā makuahine a me nā pēpē i hōʻike mua ʻia i nā lāʻau synthetic.
Vienna (Austria), 27 Mei 2022 – ʻO ka hiki ʻana o ka pilikia opioid ua hoʻonui ʻia i ka ʻōpio a me ka nāwaliwali loa, e pili ana i nā wahine hāpai a me kā lākou pēpē i ʻike mua ʻia i nā lāʻau synthetic.
Aia kekahi mau alakaʻi honua no ka mālama ʻana i nā maʻi hoʻohana lāʻau i nā wahine hāpai. Eia naʻe, no ka hōʻoia ʻana i nā hopena maikaʻi loa no nā keiki i hōʻike ʻia i loko o ka ʻōpū i nā lāʻau lapaʻau synthetic, pono mākou i ke alakaʻi piha no ka pane koke, pōkole a lōʻihi hoʻi i nā pane a me ka mālama.
No ka ʻimi ʻana i ka hopena i nā keiki pēpē o ka ʻike mua ʻana i nā lāʻau lapaʻau synthetic, ʻoi aku ka opioids synthetic, ua mālama ka United Nations Office on Drugs and Crime (UNODC) i kahi kūkākūkā loea ma ka pūnaewele me 43 mau kauka a me nā loea hoʻonaʻauao mai 14 mau ʻāina a me ʻeono mau keʻena UN kūikawā.
Hoʻopaʻa ʻia ma 1-3 Pepeluali 2022, ua kūkākūkā ke kūkākūkā i nā pono olakino, pilikanaka, hoʻonaʻauao a me ke kānāwai o nā pēpē i hānau ʻia me ka ʻike ʻana i nā neonatal i nā opioids synthetic. Ua ʻike nā poʻe komo i nā āpau i ke alakaʻi i loaʻa i nā ʻoihana olakino no ka hoʻoponopono ʻana i nā pono o nā pēpē me ka neonatal abstinence syndrome a me nā hana hoʻopaʻi lehulehu e hoʻoponopono i kēia mau āpau.
Ma ke kamaʻilio ʻana i ka hālāwai, ua ʻōlelo ʻo Mr. Alexandre Bilodeau, Hope Lunamakaʻāinana mau o Kanada i nā International Organizations ma Vienna: "ʻO nā keiki e ʻike nei i ka haʻalele ʻana mai ka ʻike ʻana i ka opioid hiki ke helu ʻia i waena o nā lālā nāwaliwali loa o ko mākou kaiāulu. Ua ʻike piha ʻo Canada i ke koʻikoʻi koʻikoʻi o ka hoʻoponopono ʻana i kēia pilikia a me kāna mau hopena olakino lehulehu. Haʻaheo loa ʻo Kanada e kākoʻo i ka UNODC Synthetic Drug Strategy a me ka hana a UNODC ma ka neonatal abstinence syndrome, "hoʻohui ʻo ia.
Ua mālama ʻia kahi ʻaha hoʻolaha hou no kēia pilikia ma kahi ʻaoʻao-event i ka 65th Session of the Commission on Narcotic Drugs ma ka lā 17 Malaki 2022. Ua komo ka hanana i kahi haʻiʻōlelo ikaika mai kahi papa papa, ʻo Ms. Lauren Dicair, he psychotherapist a me ka mea hana ola kino e hana pū ana me nā keiki makua o ka poʻe i hoʻohana i nā lāʻau lapaʻau.
Ua lawe mai ʻo Ms. Dicair i ka papaʻaina i kona ʻike ponoʻī no ka hānau ʻana me ka neonatal abstinence syndrome. Ua wehewehe ʻo ia pehea, ma ke ʻano he kanaka makua, e ʻeha mau ana ʻo ia i nā hopena: "ʻumi mau makahiki o ka trauma paʻakikī a me ke kaumaha" a me kahi "ʻano ʻano ʻano o nā hōʻailona kino" i loaʻa mai i kāna ʻike ʻana i ka lāʻau lapaʻau. Ua kāhea ʻo ia i kālā no ka noiʻi nui e pili ana i ka hopena noʻonoʻo a me ke kino o ka neonatal abstinence syndrome, a me ka hoʻonaʻauao lehulehu e kōkua i ka hōʻemi ʻana i ka stigma.
ʻO ka mea haʻiʻōlelo nui, ʻo Ms. Carol Anne Chenard, Luna Hoʻokele o Health Canada's Office of Controlled Substances, i koʻikoʻi i ka pono o ke alakaʻi ākea ākea a me nā pane multidisciplinary e pane i kēia pilikia.
